-
-
-
-
-
-
-
Jefferies Maintains 'Hold' Rating on Myriad Genetics (MYGN) Post Q1, Estimates Lowered
-
-
-
-
-
-
-
Jefferies Maintains a 'Buy' on Myriad Genetics (MYGN); Solid Q4 Supports FY13 Outlook
-
-
-
-
-
-
-
Notable Analyst Rating Changes 10/13: ALU, WNR, MYGN, MHK Upgraded; MGM, MAS, AMZN, HGG Downgraded
-
56,440 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All